| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |